Homepage | CIDRAP
COVID vaccination saved more than 5,000 US lives in 7 months in 2023-24, CDC estimates
About CIDRAP | CIDRAP
The Center for Infectious Disease Research and Policy (CIDRAP; "SID-wrap") is a global leader in addressing public health preparedness and emerging infectious disease response. Founded in 2001, CIDRAP is part of the Research and Innovation Office at the University of Minnesota. CIDRAP works to ...
COVID-19 - CIDRAP
Children with previous COVID-19 infection have a 25% to 28% higher risk of developing new gastrointestinal tract symptoms for up to 2 years than kids who did not have COVID-19. Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as ...
Infectious Disease Topics A-Z - CIDRAP
A comprehensive list of infectious diseases that CIDRAP covers. Our site is an authoritative, reliable, and timely source of science-based information about global, emerging infectious diseases.
Nursing homes used unproven COVID measures and didn't use
Feb 4, 2025 · Few of the many nonpharmacologic efforts to mitigate the spread of COVID-19 in nursing homes during the pandemic were evidence-based, and vaccinations and antiviral drugs were underused, concludes a scoping review published late last week in JAMA Health Forum.. Boston University–led researchers analyzed the federal COVID-19 Skilled Nursing Facility …
Data: Despite high risk of poor outcomes, only 1% of pregnant …
1 day ago · Andrey Popov / iStock. Only 1.3% of pregnant US COVID-19 patients received an antiviral drug to reduce the risk of severe illness in winter 2021 to fall 2022, 67% less than their nonpregnant counterparts, finds a study published last week in Clinical Infectious Diseases.. University of California Los Angeles researchers analyzed claims data on antiviral drug …
Episode 176: Responding to Shock, Awe, and Censorship
5 days ago · In "Responding to Shock, Awe, and Censorship" Dr. Osterholm and Chris Dall provide updates on the latest news in the federal government and how it is impacting public health locally and globally. Dr. Osterholm also discusses the latest developments in H5N1 avian flu and answers an ID query about the tuberculosis outbreak in Kansas. Anatomy of a Failure: Why …
FDA approves combination antibiotic for difficult-to-treat
1 day ago · The World Health Organization (WHO) last week released its global research agenda for antimicrobial resistance (AMR) in human health.. Designed to fill the substantial knowledge gaps on AMR that have hampered development of evidence-based policies and interventions and contributed to the stalled progress on national AMR action plans, the agenda includes 33 …
Our Projects - CIDRAP
The Centers of Excellence for Influenza Research and Surveillance (CEIRS) Network Pandemic Research Response Planning project is a cross-center collaborative initiative aimed at enhancing the CEIRS network’s ability to mobilize its scientific expertise and capabilities during an influenza pandemic or pre-pandemic situation and provide research-based knowledge to inform the U.S. …
CIDRAP in the News | CIDRAP
Oct 11, 2024 · Jan 8, 2025 CIDRAP announces the release a detailed, state-of-the-art report on preparedness and response gaps and needs should chronic wasting disease (CWD) jump from cervids such as deer to farm animals or people.. Oct 27, 2024 Advancing influenza vaccines: A review of next-generation candidates and their potential for global health impact paper …